FindTrial
Sign In

D000622

5 trials

Sponsors

Wada Takahito, Kinouchi Kenichiro, Ito Hiroki, Nakamura Tomoki, Yoneoka Yutaka

Conditions

ATR-X syndrome infant, intellectual disability, epigenetics, guanine quadruplexProstate cancer Prostate cancerSoft tissue sarcoma Soft tissue sarcomanoneovarian, fallopian tube and peritoneal cancer Carcinoma, Ovarian Epithelial

Phase 2

Physician-initiated clinical trial in patients with 5-aminolevulinic acid-induced ATR-X syndrome.
Active, not recruitingJPRN-jRCT2051220062
Wada TakahitoATR-X syndrome infant, intellectual disability, epigenetics, guanine quadruplex
Start: 2022-07-14Target: 5Updated: 2026-06-29
Development of a novel diagnostic method for ovarian cancer lesions using 5-aminolevulinic acid
RecruitingJPRN-jRCTs051240230
Yoneoka Yutakaovarian, fallopian tube and peritoneal cancer Carcinoma, Ovarian Epithelial
Start: 2025-03-17Target: 15Updated: 2026-06-29
5-ALA PDD STS
RecruitingJPRN-jRCTs041260021
Nakamura TomokiSoft tissue sarcoma Soft tissue sarcoma
Start: 2026-06-17Target: 28Updated: 2026-06-29

Unknown Phase

ALASAP STUDY
Active, not recruitingJPRN-jRCTs031190094
Kinouchi Kenichironone
Start: 2020-02-20Target: 54Updated: 2026-06-29
Study to Evaluate Whether Oral 5-Aminolevulinic Acid Helps Visualize Cancer Margins During Prostate Cancer Surgery
RecruitingJPRN-jRCTs031250607
Ito HirokiProstate cancer Prostate cancer
Start: 2025-12-26Target: 10Updated: 2026-06-29